Compare Cytokinetics Inc (CYTK) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs QUALCOMM, Inc. — how do they compare? Cytokinetics Inc trades at $82.03 (market cap $11.16B), while QUALCOMM, Inc. trades at $180.1 (market cap $193.91B). The key difference: QUALCOMM, Inc. is far larger — about 17.4× Cytokinetics Inc's market cap, and QUALCOMM, Inc. pays a 2% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | QCOM | |
|---|---|---|
Market Cap | $11.16B | $193.91B |
Sector | Technology | Technology |
52-Week High | $87.26 | $251.10 |
52-Week Low | $33.23 | $124.07 |
Enterprise Value | $11.63B | $199.39B |
Dividend Yield | — | 2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Qualcomm (QCOM) trades at $178.08, down 5.86% over 24 hours, with a bearish technical signal and mixed sentiment. The stock shows strong profitability with a 22.31% net income margin and consistent earnings beats in recent quarters. Recent news highlights its AI and data center diversification amid smartphone market challenges, with CEO Cristiano Amon projecting 'multiple billions' in data center revenue ahead (MarketBeat, June 2, 2026).
The outlook balances growth in AI and automotive against near-term margin pressures and competition. Analysts see upside to a $222.53 consensus target, but risks include Nvidia's entry into PC chips and soft smartphone demand. The stock offers value at a P/E of 19.78, with dividends providing income support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
